SPARC Ltd : Q4FY17 Results
SPARC Ltd. reported its results for the quarter ended March 31, 2017 on Friday.
The company's total sales for Q4FY17 came in at Rs 41.6 crore, which represents 80.5 per cent sequential increase and 1.04 per cent YoY increase.
Its operating loss for the quarter amounted to Rs 36 crore. The company reported net loss of Rs 32.27 crore as against net loss of Rs. 66.33 in Q3FY17.
The stock opened at Rs 321.8 and touched an intra-day low of Rs 309.6 and finally closed at Rs 315.8 on the BSE.
Sun Pharma Advanced Research Company Ltd is a pharma research and drug discovery company. The company operates in only one segment- pharmaceuticals research & development. It undertakes projects in research and technology for new chemical entities (NCEs) or new molecules, and novel drug delivery systems (NDDS). It designs and develops therapies for allergy and inflammation.